NCT07180654

Brief Summary

Aim 1: Assess how menstrual cycle phase affects motor cortex plasticity in females. Aim 2: Compare motor cortex plasticity between males and females across the same time points, identifying potential sex differences in TMS response. Aim 3: Examine associations between serum hormone levels and TMS-induced plasticity within and between sexes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
30mo left

Started Dec 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress14%
Dec 2025Oct 2028

First Submitted

Initial submission to the registry

September 2, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

September 18, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 15, 2025

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2028

Last Updated

January 9, 2026

Status Verified

January 1, 2026

Enrollment Period

2.9 years

First QC Date

September 2, 2025

Last Update Submit

January 7, 2026

Conditions

Keywords

transcranial magnetic stimulationcortical excitabilityhormones

Outcome Measures

Primary Outcomes (2)

  • Single-pulse TMS

    Single-pulse TMS: Cortical excitability curves will be measured before and after a single 1800-pulse train of iTBS. Motor Evoked Potentials (MEPs) will be recorded from the right FDI muscle at 7 distinct intensities ranging from -20% to + 40% of MT. Single pulses will be delivered once every 10±3 seconds to the left motor cortex at random intensities in the above range to avoid habituation across pulses. Across the session, a total of 70 pulses will be delivered before and after iTBS, 10 at each intensity.

    Will be collected during 3 visits over the course of a 2 month timeframe during different phases of the menstrual cycle (in females).

  • Paired pulse stimulation

    Paired-pulse stimulation: Subjects will undergo paired-pulse stimulation to measure both intracortical inhibition and intracortical facilitation. For intracortical inhibition, subjects will receive a conditioning pulse at 80% MT 4 seconds before the test pulse at 120% MT. For intracortical facilitation, subjects will receive a conditioning pulse at 120% MT 15s before the test pulse at 120% MT. Across the session, a total of 60 paired pulses will be delivered before and after iTBS, 30 at each ISI.

    Will be collected during 3 visits over the course of a 2 month timeframe during different phases of the menstrual cycle (in females).

Study Arms (1)

Volunteers

Single group design

Device: transcranial magnetic stimulation

Interventions

Subjects will receive a series of 60 10s trains that will be presented over the course of the \~3.5 min session. Each train will consist of 2 s of stimulation with an 8 s ITI. During the 2 s of stimulation, 10, 50 Hz bursts will be repeated at intervals of 200 ms (5 Hz). iTBS will be administered at 100% of the motor threshold (MT).

Volunteers

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the community in the Philadelphia Metro Area.

You may qualify if:

  • Able to give their consent
  • If female, must have menstrual cycles of normal frequency, regularity, and duration.

You may not qualify if:

  • Non-English speaking
  • Any medical condition that increases risk for TMS
  • History of seizure
  • History of epilepsy
  • Increased risk of seizure for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Participants may be asked to provide blood samples. This analysis may measure serum estradiol, progesterone, testosterone, luteinizing hormone, and/or follicle-stimulating hormone. No more than 10 mL of blood may be collected at each visit. Blood will be collected at Penn.

MeSH Terms

Interventions

Transcranial Magnetic Stimulation

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Nicholas Balderston, PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2025

First Posted

September 18, 2025

Study Start

December 15, 2025

Primary Completion (Estimated)

October 31, 2028

Study Completion (Estimated)

October 31, 2028

Last Updated

January 9, 2026

Record last verified: 2026-01

Locations